Bio|Path Holdings Inc. filed SEC Form 8|K
SEC Filings - ImmunityBio, Inc.
Filing Group, View. Nov 12, 2024, 10-Q. Quarterly report which ... 8-K. Report of unscheduled material events or corporate event.
united states securities and exchange commission - form 8-k
ORGANOVO HOLDINGS, INC. (Exact name of registrant as specified in its charter). Commission File Number: 001-35996. Delaware. 27-1488943. (State ...
SEC Filing - Investor Overview - Invivyd
a biotechnology company. Mr. Heyman previously served as the President of Johnson & Johnson's Corporate Venture Capital Group, the venture capital arm of ...
Small Entity Compliance Guide - FinCEN
section 2 of the Bank Holding Company Act of 1956. (12 U.S.C. 1841). □ Yes ... form) filed with the Securities and Exchange. Commission or will be so ...
Bio-Path Holdings Reports Third Quarter 2024 Financial Results
Expands DNAbilize® Technology Beyond Oncology into Obesity Conference Call to be Held Today at 8:30 A.M. ET HOUSTON, Nov.
Filing Group, View. Nov 12, 2024, SC 13G/A. An amendment to the SC 13G ... 8-K. Report of unscheduled material events or corporate event. Current Reports.
EX-101.INS - XBRL INSTANCE DOCUMENT View HTML · 10-K. Annual report which provides a comprehensive overview of the company for the past year. Mar 12, 2020.
SEC Filings - BioXcel Therapeutics
8-K. Report of unscheduled material events or corporate event. Nov 14, 2024 ... Copyright © 2024 BioXcel Therapeutics, Inc. All Rights Reserved. Privacy ...
Filing date · Description · Form, View. 11.12.2024. Report of unscheduled material events or corporate event. 8-K · 0000950170-24-124576.
Ginkgo Bioworks Holdings, Inc. (Form: 8-K, Received - EDGAR Online
The Company's Class A common stock and public warrants are deemed to be registered under Section 12(b) of the Exchange Act, and the Company will hereafter file ...
Bio-Path Holdings Reports Third Quarter 2024 Financial Results
Expands DNAbilize® Technology Beyond Oncology into Obesity. Conference Call to be Held Today at 8:30 A.M. ET. HOUSTON, Nov.
Financials & Filings | Climb Bio
SEC Filings ; Apr 29, 2024. Amendment to a previously filed 10-K · 10-K/A ; Mar 07, 2022. Annual report which provides a comprehensive overview of the company for ...
VBHI / Verde Bio Holdings, Inc. - SEC Filings, Annual Report ... - Fintel
Form 10-Q Quarterly Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. 2020-02-12, 8-K. Entry into a Material Definitive Agreement, ...
SEC Filings - Day One Biopharmaceuticals, Inc.
Oct 31, 2024. Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing. 144 ; Oct 30, 2024. Report of unscheduled ...
Form 8-K for Fortrea Holdings INC filed 11/29/2023
Securities registered pursuant to Section 12(b) of the Exchange Act. Title of Each Class Trading Symbol Name of exchange on which registered.
Financials & Filings - 89bio, Inc.
SEC Filings. Group. All Filings, 3,4,5, Annual Filings, Current ... Amendment to a previously filed 8-K. Current Reports. 0001193125-24 ...
SEC Filings - Investor Relations | PROCEPT BioRobotics Corp
Nov 4, 2024. An amendment to the SC 13G filing. SC 13G/A ; Oct 31, 2024. Report of unscheduled material events or corporate event. 8-K ; Oct ...
Tevogen Bio Holdings Inc. Common Stock (TVGN) SEC Filings
Find the latest SEC Filings data for Tevogen Bio Holdings Inc. Common Stock (TVGN) including 10-K and 10-Q forms at Nasdaq ... 8-K, 08/23/2024, 08/20/2024. HTML ...
Download Forms / Online Filing Instructions | WA Secretary of State
K-12 & CollegeOpen submenu ... The following filings are specific to the business entity type. Profit Corporation, Filing Fees, Mail-In Forms, Online Filing ...
Financials & Filings - BioCardia
XBRL viewer for form 8-K filed on Nov 13, 2024. Nov 13, 2024, 10-Q · Quarterly ... BioCardia®, CardiAMP™, CardiALLO™, Helix™, and Morph® are trademarks of ...